Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;53(9):1030-1037.
doi: 10.1111/apt.16324. Epub 2021 Mar 25.

Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease

Jung Gil Park  1   2 , Jinho Jung  1 , Kritin K Verma  1 , Min Kyu Kang  2 , Egbert Madamba  1 , Scarlett Lopez  1 , Aed Qas Yonan  1 , Amy Liu  1 , Ricki Bettencourt  1 , Claude Sirlin  3 , Rohit Loomba  1   4
Affiliations

Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease

Jung Gil Park et al. Aliment Pharmacol Ther. 2021 May.

Abstract

Background: Magnetic resonance elastography (MRE) is a reliable non-invasive alternative to liver biopsy for assessing liver fibrosis. There are limited data regarding an association between liver fibrosis by MRE and risk of cardiovascular disease (CVD).

Aim: To investigate the association of high-risk CVD phenotype determined by coronary artery calcification (CAC) with liver fibrosis by MRE in patients with non-alcoholic fatty liver disease (NAFLD).

Method: This was a cross-sectional analysis of well-characterised, prospective cohorts including 105 patients with NAFLD (MR imaging-derived proton density fat fraction ≥ 5%) with contemporaneous cardiac computed tomography (CT) and MRE. Patients were assessed using MRE for liver stiffness, and cardiac CT for the presence of CAC (defined as coronary artery calcium score > 0). Odds of presence of CAC were analysed using logistic regression analysis.

Results: The average age and body mass index were 54.9 years and 32.9 kg/m2 respectively. In this cohort, 49.5% of patients had CAC and 35.2% had significant liver fibrosis (defined as MRE ≥2.97 kPa). Compared to patients without CAC, those with CAC were older (50.0 [39.0-59.0] vs 63.0 [55.5-67.5], P < 0.001) and had higher Framingham risk score (FRS, 1.0 [0.5-3.5] vs 6.0 [2.0-12.0], P < 0.001). In multivariable-adjusted analysis, liver stiffness as a continuous trait on MRE was independently associated with the presence of CAC in a sex and age-adjusted model (adjusted odd ratios [aOR] = 2.23, 95% confidence interval [CI] = 1.31-4.34, P = 0.007) as well as in a FRS-adjusted model (aOR = 2.16, 95% CI = 1.29-4.09, P = 0.008). When analysed as a dichotomous trait, significant fibrosis (MRE-stiffness ≥2.97 kPa) remained independently associated with the presence of CAC in both FRS-adjusted model and sex and age-adjusted model (aOR = 3.21-3.53, P = 0.013-0.017). In addition, CAC was more prevalent in patients with significant fibrosis than those without as determined by MRE (67.6% vs 39.7%, P = 0.012).

Conclusion: Liver stiffness determined by MRE is an independent predictor for the presence of CAC in patients with NAFLD. Patients with NAFLD and significant fibrosis by MRE should be considered for further cardiovascular risk assessment, regardless of their FRS.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Predicted probability of presence of coronary artery calcification (defined as coronary artery calcium score > 0) according to liver stiffness by magnetic resonance elastography in patient with non-alcoholic fatty liver disease (a) Sex and age-adjusted model, (b) Framingham risk score-adjustedmodel *The area covered by the prediction intervals is 95% confidence interval. MRE, magnetic resonance elastography
Figure 2.
Figure 2.
Odds ratio for the presence of coronary artery calcification (defined as coronary artery calcium score > 0) in sex and age-adjusted and FRS-adjusted logistic analysis in patients with non-alcoholic fatty liver disease and significant fibrosis (defined as MRE ≥2.97kPa) MRE, magnetic resonance elastography; FRS, Framingham Risk Score; CAC, coronary artery calcification
Figure 3.
Figure 3.
Prevalence of the presence of coronary artery calcification (defined as coronary artery calcium score > 0) in patients with non-alcoholic fatty liver disease according to significant fibrosis (defined as MRE≥2.97kPa) MRE, magnetic resonance elastography
See this image and copyright information in PMC

Comment in

References

    1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013;10(11):686–690. - PubMed
    1. Yoo JJ, Kim W, Kim MY, et al. Recent research trends and updates on nonalcoholic fatty liver disease. Clin Mol Hepatol 2019;25(1):1–11. - PMC - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328–357. - PubMed
    1. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66(6):1138–1153. - PubMed
    1. Loomba R, Adams LA. The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH. Hepatology 2019;70(6):1885–1888. - PMC - PubMed

Publication types

MeSH terms